Inactive Instrument

BioPlus Acquisition Corp. Stock

BIOS

KYG112171171

Chart BioPlus Acquisition Corp.

Duration

Period

Style

Dynamic Chart

Latest news about BioPlus Acquisition Corp.

BioPlus Acquisition Corp.(NasdaqGM:BIOS) dropped from NASDAQ Composite Index	23-10-10	CI
BioPlus Acquisition, Avertix Medical Terminate Business Combination Deal	23-10-04	MT
Avertix Medical, Inc. terminated the acquisition of BioPlus Acquisition Corp. from BioPlus Sponsor LLC, Highbridge Capital Management, LLC, Saba Capital Management, L.P., Cantor Fitzgerald & Co, Investment Arm and others in a reverse merger transaction.	23-10-03	CI
BioPlus Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
BioPlus Acquisition Corp. announced that it has received $1.5 million in funding	23-06-01	CI
BioPlus Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Avertix Medical, Inc. entered into a definitive merger agreement to acquire BioPlus Acquisition Corp. from BioPlus Sponsor LLC, Highbridge Capital Management, LLC, Saba Capital Management, L.P., Cantor Fitzgerald & Co, Investment Arm and others for approximately $170 million in a reverse merger transaction.	23-05-02	CI
BioPlus Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
BioPlus Acquisition Corp. Auditor Raises 'Going Concern' Doubt	23-03-30	CI
BioPlus Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03	CI
BioPlus Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-10	CI
Certain Class B Ordinary Shares of BioPlus Acquisition Corp. are subject to a Lock-Up Agreement Ending on 1-JUN-2022.	22-05-31	CI
BioPlus Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
BioPlus Acquisition Corp. Reports Earnings Results for the Eleven Months Ended December 31, 2021	22-03-11	CI
BioPlus Acquisition Corp.(NasdaqGM:BIOS) added to NASDAQ Composite Index	22-01-31	CI

More news

Press releases BioPlus Acquisition Corp.

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate	23-10-04	AQ
Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring	23-08-16	AQ
Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors	23-07-17	AQ
Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando	23-06-13	AQ
BIOPLUS ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23-06-08	AQ

More press releases

Managers and Directors - BioPlus Acquisition Corp.

Managers	Title	Age	Since
Ross Haghighat CEO	Chief Executive Officer	60	-
Sapna R. Srivastava PRN	Corporate Officer/Principal	53	-
Steven Fletcher PRN	Corporate Officer/Principal	56	-

Members of the board	Title	Age	Since
Stephen Sherwin BRD	Director/Board Member	75	21-11-30
Jonathan Rigby CHM	Chairman	56	21-06-30
Louis Lange BRD	Director/Board Member	72	21-11-30

More insiders

ETFs positioned on BioPlus Acquisition Corp.

Name	Weight	AuM	1st Jan change	Investor Rating
ROBINSON ALTERNATIVE YIELD PRE-MERGER SPAC ETF - USD	1.14%	15 M€	+0.04%	-
CROSSINGBRIDGE PRE-MERGER SPAC ETF - USD	0.32%	66 M€	+1.68%	-

More ETFs positioned on BioPlus Acquisition Corp.

BioPlus Acquisition Corp. is a blank check company. The Company is formed for the purpose effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company intends to focus its search on companies in the life sciences industry. The Company has not commenced any operations nor generated any revenue.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+119.94%	5.26B
SCREAMING EAGLE ACQUISITION CORP.	+1.60%	1.01B
CHURCHILL CAPITAL CORP VII	+2.29%	983M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+27.64%	834M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+1.80%	617M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+23.11%	560M

Shell Companies